Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy - current status and future developments

International Journal of Developmental Biology

Volumn 55, Issue 4-5, 2011, Pages 407-417

  Templin, Christian ^a   Lüscher, Thomas F ^a   Landmesser, Ulf ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Myocardial infarction; Myocardial regeneration; Stem and progenitor cell

Indexed keywords

ACUTE HEART INFARCTION; ADULT STEM CELL; ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL TRANSFER; CELL TRANSPLANTATION; CLINICAL STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HEART FUNCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TISSUE REGENERATION; TISSUE REPAIR;

ADULT STEM CELLS; ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 79960993428     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103219ct     Document Type: Article

References (122)

1. ABDEL-LATIF A, BOLLI R, TLEYJEH IM, MONTORI VM, PERIN EC, HORNUNG CA, ZUBA-SURMA EK, AL-MALLAH M, DAWN B (2007). Adult bone marrowderived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167: 989-997.
2. ABKOWITZ JL, CATLIN SN, MCCALLIE MT, GUTTORP P (2002). Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 100: 2665-2667.
3. AICHER A, BRENNER W, ZUHAYRA M, BADORFF C, MASSOUDI S, ASSMUS B, ECKEY T, HENZE E, ZEIHER AM, DIMMELER S (2003). Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107: 2134-2139.
4. AMADO LC, SCHULERI KH, SALIARIS AP, BOYLE AJ, HELM R, OSKOUEI B, CENTOLA M, ENEBOE V, YOUNG R, LIMA JA, LARDO AC, HELDMAN AW, HARE JM (2006). Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol 48: 2116-2124.
5. ASSMUS B, FISCHER-RASOKAT U, HONOLD J, SEEGER FH, FICHTLSCHERER S, TONN T, SEIFRIED E, SCHACHINGER V, DIMMELER S, ZEIHER AM (2007). Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARECHD Registry. Circ Res 100: 1234-1241.
6. ASSMUS B, ROLF A, ERBS S, ELSASSER A, HABERBOSCH W, HAMBRECHT R, TILLMANNS H, YU J, CORTI R, MATHEY DG, HAMM CW, SUSELBECK T, TONN T, DIMMELER S, DILL T, ZEIHER AM, SCHACHINGER V (2010). Clinical outcome 2 years after intracoronary administration of bone marrowderived progenitor cells in acute myocardial infarction. Circ Heart Fail 3: 89-96.
7. ASSMUS B, SCHACHINGER V, TEUPE C, BRITTEN M, LEHMANN R, DOBERT N, GRUNWALD F, AICHER A, URBICH C, MARTIN H, HOELZER D, DIMMELER S, ZEIHER AM (2002). Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 3009-3017.
8. BARBASH IM, CHOURAQUI P, BARON J, FEINBERG MS, ETZION S, TESSONE A, MILLER L, GUETTA E, ZIPORI D, KEDES LH, KLONER RA, LEOR J (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863-868.
9. BELTRAMI AP, BARLUCCHI L, TORELLA D, BAKER M, LIMANA F, CHIMENTI S, KASAHARA H, ROTA M, MUSSO E, URBANEK K, LERI A, KAJSTURA J, NADAL-GINARD B, ANVERSA P (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
10. BURCHFIELD JS, IWASAKI M, KOYANAGI M, URBICH C, ROSENTHAL N, ZEIHER AM, DIMMELER S (2008). Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 103: 203-211.
11. BURT RK, LOH Y, PEARCE W, BEOHAR N, BARR WG, CRAIG R, WEN Y, RAPP JA, KESSLER J (2008). Clinical applications of blood-derived and marrowderived stem cells for nonmalignant diseases. JAMA 299: 925-936.
12. CASPI O, HUBER I, KEHAT I, HABIB M, ARBEL G, GEPSTEIN A, YANKELSON L, ARONSON D, BEYAR R, GEPSTEIN L (2007). Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50: 1884-1893.
13. CHALLEN GA, LITTLE MH'(2006). A side order of stem cells: the SP phenotype. Stem Cells 24: 3-12.
14. CHENG Z, OU L, ZHOU X, LI F, JIA X, ZHANG Y, LIU X, LI Y, WARD CA, MELO LG, KONG D (2008). Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16: 571-579.
15. CONGET PA, MINGUELL JJ (1999). Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181: 67-73.
16. CRISOSTOMO PR, ABARBANELL AM, WANG M, LAHM T, WANG Y, MELDRUM DR (2008). Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. Am J Physiol Heart Circ Physiol 295: H1726-1735.
17. DIB N, DINSMORE J, LABABIDI Z, WHITE B, MORAVEC S, CAMPBELL A, ROSENBAUM A, SEYEDMADANI K, JABER WA, RIZENHOUR CS, DIETHRICH E (2009). One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv 2: 9-16.
18. DOMINICI M, LE BLANC K, MUELLER I, SLAPER-CORTENBACH I, MARINI F, KRAUSE D, DEANS R, KEATING A, PROCKOP D, HORWITZ E (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
19. ERBS S, LINKE A, SCHACHINGER V, ASSMUS B, THIELE H, DIEDERICH KW, HOFFMANN C, DIMMELER S, TONN T, HAMBRECHT R, ZEIHER AM, SCHULER G (2007). Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 116: 366-374.
20. FORD ES, AJANI UA, CROFT JB, CRITCHLEY JA, LABARTHE DR, KOTTKE TE, GILES WH, CAPEWELL S (2007). Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 356: 2388-2398.
21. FREYMAN T, POLIN G, OSMAN H, CRARY J, LU M, CHENG L, PALASIS M, WILENSKY RL (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27: 1114-1122.
22. FUKUSHIMA S, VARELA-CARVER A, COPPEN SR, YAMAHARA K, FELKIN LE, LEE J, BARTON PJ, TERRACCIANO CM, YACOUB MH, SUZUKI K (2007). Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115: 2254-2261.
23. GEOGHEGAN E, BYRNES L (2008). Mouse induced pluripotent stem cells. Int J Dev Biol 52: 1015-1022.
24. GIANNOTTI G, DOERRIES C, MOCHARLA PS, MUELLER MF, BAHLMANN FH, HORVÀTH T, JIANG H, SORRENTINO SA, STEENKEN N, MANES C, MARZILLI M, RUDOLPH KL, LÜSCHER TF, DREXLER H, LANDMESSER U (2010). Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 55: 1389-1397.
25. GIORDANO FJ, GERBER HP, WILLIAMS SP, VANBRUGGEN N, BUNTING S, RUIZ-LOZANO P, GU Y, NATH AK, HUANG Y, HICKEY R, DALTON N, PETERSON KL, ROSS J, JR., CHIEN KR, FERRARA N (2001). A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 98: 5780-5785.
26. GNECCHI M, HE H, LIANG OD, MELO LG, MORELLO F, MU H, NOISEUX N, ZHANG L, PRATT RE, INGWALL JS, DZAU VJ (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368.
27. GNECCHI M, ZHANG Z, NI A, DZAU VJ (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219.
28. GRUH I, BEILNER J, BLOMER U, SCHMIEDL A, SCHMIDT-RICHTER I, KRUSE ML, HAVERICH A, MARTIN U (2006). No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 113: 1326-1334.
29. HIERLIHY AM, SEALE P, LOBE CG, RUDNICKI MA, MEGENEY LA (2002). The post-natal heart contains a myocardial stem cell population. FEBS Lett 530: 239-243.
30. HIRSCH A, NIJVELDT R, VAN DER VLEUTEN PA, BIEMOND BJ, DOEVENDANS PA, VAN ROSSUM AC, TIJSSEN JG, ZIJLSTRA F, PIEK JJ (2006). Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial-a prospective, multicenter, randomized trial. Am Heart J 152: 434-441.
31. HOFMANN M, WOLLERT KC, MEYER GP, MENKE A, ARSENIEV L, HERTENSTEIN B, GANSER A, KNAPP WH, DREXLER H (2005). Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111: 2198-2202.
32. HRISTOV M, HEUSSEN N, SCHOBER A, WEBER C (2006). Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med 10: 727-733.
33. HUR J, YOON CH, KIM HS, CHOI JH, KANG HJ, HWANG KK, OH BH, LEE MM, PARK YB (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293.
34. IMANISHI T, MORIWAKI C, HANO T, NISHIO I (2005). Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 23: 1831-1837.
35. IWASAKI H, KAWAMOTO A, WILLWERTH C, HORII M, OYAMADA A, AKIMARU H, SHIBATA T, HIRAI H, SUEHIRO S, WNENDT S, FODOR WL, ASAHARA T (2009). Therapeutic potential of unrestricted somatic stem cells isolated from placental cord blood for cardiac repair post myocardial infarction. Arterioscler Thromb Vasc Biol 29: 1830-1835.
36. JACKSON KA, MAJKA SM, WANG H, POCIUS J, HARTLEY CJ, MAJESKY MW, ENTMAN ML, MICHAEL LH, HIRSCHI KK, GOODELL MA (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402.
37. JANSSENS S, DUBOIS C, BOGAERT J, THEUNISSEN K, DEROOSE C, DESMET W, KALANTZI M, HERBOTS L, SINNAEVE P, DENS J, MAERTENS J, RADEMAKERS F, DYMARKOWSKI S, GHEYSENS O, VAN CLEEMPUT J, BORMANS G, NUYTS J, BELMANS A, MORTELMANS L, BOOGAERTS M, VAN DE WERF F (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367: 113-121.
38. KIM BO, TIAN H, PRASONGSUKARN K, WU J, ANGOULVANT D, WNENDT S, MUHS A, SPITKOVSKY D, LI RK (2005). Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112: I96-104.
39. KIM D, KIM CH, MOON JI, CHUNG YG, CHANG MY, HAN BS, KO S, YANG E, CHA KY, LANZA R, KIM KS (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476.
40. KINNAIRD T, STABILE E, BURNETT MS, LEE CW, BARR S, FUCHS S, EPSTEIN SE (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685.
41. KOCHER AA, SCHUSTER MD, SZABOLCS MJ, TAKUMA S, BURKHOFF D, WANG J, HOMMA S, EDWARDS NM, ITESCU S (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436.
42. LAFLAMME MA, CHEN KY, NAUMOVA AV, MUSKHELI V, FUGATE JA, DUPRAS SK, REINECKE H, XU C, HASSANIPOUR M, POLICE S, O'SULLIVAN C, COLLINS L, CHEN Y, MINAMI E, GILL EA, UENO S, YUAN C, GOLD J, MURRY CE (2007). Cardiomyocytes derived from human embryonic stem cells in prosurvival factors enhance function of infarcted rat hearts. Nat Biotechnol 25: 1015-1024.
43. LANDMESSER U (2009). Bone marrow cell therapy after myocardial infarction. What should we select? Eur Heart J 30: 1310-1312.
44. LANDMESSER U, DREXLER H (2005). Chronic heart failure: an overview of conventional treatment versus novel approaches. Nat Clin Pract Cardiovasc Med 2: 628-638.
45. LANDMESSER U, ENGBERDING N, BAHLMANN FH, SCHAEFER A, WIENCKE A, HEINEKE A, SPIEKERMANN S, HILFIKER-KLEINER D, TEMPLIN C, KOTLARZ D, MUELLER M, FUCHS M, HORNIG B, HALLER H, DREXLER H (2004). Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 110: 1933-1939.
46. LANDMESSER U, WOLLERT KC, DREXLER H (2009). Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc Res 81: 519-527.
47. LAUGWITZ KL, MORETTI A, LAM J, GRUBER P, CHEN Y, WOODARD S, LIN LZ, CAI CL, LU MM, RETH M, PLATOSHYN O, YUAN JX, EVANS S, CHIEN KR (2005). Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653.
48. LI Z, LEE A, HUANG M, CHUN H, CHUNG J, CHU P, HOYT G, YANG P, ROSENBERG J, ROBBINS RC, WU JC (2009). Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol 53: 1229-1240.
49. LIPINSKI MJ, BIONDI-ZOCCAI GG, ABBATE A, KHIANEY R, SHEIBAN I, BARTUNEK J, VANDERHEYDEN M, KIM HS, KANG HJ, STRAUER BE, VETROVEC GW (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50: 1761-1767.
50. LOSORDO DW, SCHATZ RA, WHITE CJ, UDELSON JE, VEERESHWARAYYA V, DURGIN M, POH KK, WEINSTEIN R, KEARNEY M, CHAUDHRY M, BURG A, EATON L, HEYD L, THORNE T, SHTURMAN L, HOFFMEISTER P, STORY K, ZAK V, DOWLING D, TRAVERSE JH, OLSON RE, FLANAGAN J, SODANO D, MURAYAMA T, KAWAMOTO A, KUSANO KF, WOLLINS J, WELT F, SHAH P, SOUKAS P, ASAHARA T, HENRY TD (2007). Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa doubleblind, randomized controlled trial. Circulation 115: 3165-3172.
51. LUECKE N, TEMPLIN C, MUETZELBURG MV, NEUMANN D, JUST I, PICH A (2010). Secreted proteome of the murine multipotent hematopoietic progenitor cell line DKmix. Rapid Commun Mass Spectrom 24: 561-570.
52. LUNDE K, SOLHEIM S, AAKHUS S, ARNESEN H, ABDELNOOR M, EGELAND T, ENDRESEN K, ILEBEKK A, MANGSCHAU A, FJELD JG, SMITH HJ, TARALDSRUD E, GROGAARD HK, BJORNERHEIM R, BREKKE M, MULLER C, HOPP E, RAGNARSSON A, BRINCHMANN JE, FORFANG K (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355: 1199-1209.
53. LUNDE K, SOLHEIM S, FORFANG K, ARNESEN H, BRINCH L, BJORNERHEIM R, RAGNARSSON A, EGELAND T, ENDRESEN K, ILEBEKK A, MANGSCHAU A, AAKHUS S (2008). Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J Am Coll Cardiol 51: 674-676.
54. MAKELA J, ANTTILA V, YLITALO K, TAKALO R, LEHTONEN S, MAKIKALLIO T, NIEMELA E, DAHLBACKA S, TIKKANEN J, KIVILUOMA K, JUVONEN T, LEHENKARI P (2009). Acute homing of bone marrow-derived mononuclear cells in intramyocardial vs. intracoronary transplantation. Scand Cardiovasc J 43: 366-373.
55. MAKINO S, FUKUDA K, MIYOSHI S, KONISHI F, KODAMA H, PAN J, SANO M, TAKAHASHI T, HORI S, ABE H, HATA J, UMEZAWA A, OGAWA S (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705.
56. MANGI AA, NOISEUX N, KONG D, HE H, REZVANI M, INGWALL JS, DZAU VJ (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201.
57. MARTIN-RENDON E, BRUNSKILL SJ, HYDE CJ, STANWORTH SJ, MATHUR A, WATT SM (2008). Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29: 1807-1818.
58. MAURITZ C, SCHWANKE K, REPPEL M, NEEF S, KATSIRNTAKI K, MAIER LS, NGUEMO F, MENKE S, HAUSTEIN M, HESCHELER J, HASENFUSS G, MARTIN U (2008). Generation of functional murine cardiac myocytes from Induced Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117: 1189-1200.
59. MENASCHE P, HAGEGE AA, VILQUIN JT, DESNOS M, ABERGEL E, POUZET B, BEL A, SARATEANU S, SCORSIN M, SCHWARTZ K, BRUNEVAL P, BENBUNAN M, MAROLLEAU JP, DUBOC D (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1083.
60. MESSINA E, DE ANGELIS L, FRATI G, MORRONE S, CHIMENTI S, FIORDALISO F, SALIO M, BATTAGLIA M, LATRONICO MV, COLETTA M, VIVARELLI E, FRATI L, COSSU G, GIACOMELLO A (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95: 911-921.
61. MEYER GP, WOLLERT KC, LOTZ J, PIRR J, RAGER U, LIPPOLT P, HAHN A, ICHTNER S, SCHAEFER A, ARSENIEV L, GANSER A, DREXLER H (2009). Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30: 2978-2984.
62. MEYER GP, WOLLERT KC, LOTZ J, STEFFENS J, LIPPOLT P, FICHTNER S, HECKER H, SCHAEFER A, ARSENIEV L, HERTENSTEIN B, GANSER A, DREXLER H (2006). Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113: 1287-1294.
63. MIN JY, YANG Y, SULLIVAN MF, KE Q, CONVERSO KL, CHEN Y, MORGAN JP, XIAO YF (2003). Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125: 361-369.
64. MIROTSOU M, ZHANG Z, DEB A, ZHANG L, GNECCHI M, NOISEUX N, MU H, PACHORI A, DZAU V (2007). Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA 104: 1643-1648.
65. MOSCOSO I, BARALLOBRE J, DE ILARDUYA OM, ANON P, FRAGA M, CALVINO R, ALDAMA G, DOMENECH N (2009). Analysis of different routes of administration of heterologous 5-azacytidine-treated mesenchymal stem cells in a porcine model of myocardial infarction. Transplant Proc 41: 2273-2275.
66. MURRY CE, KELLER G (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132: 661-680.
67. MURRY CE, SOONPAA MH, REINECKE H, NAKAJIMA H, NAKAJIMA HO, RUBART M, PASUMARTHI KB, VIRAG JI, BARTELMEZ SH, POPPA V, BRADFORD G, DOWELL JD, WILLIAMS DA, FIELD LJ (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668.
68. NELSON TJ, MARTINEZ-FERNANDEZ A, YAMADA S, PEREZ-TERZIC C, IKEDA Y, TERZIC A (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120: 408-416.
69. NUSSBAUM J, MINAMI E, LAFLAMME MA, VIRAG JA, WARE CB, MASINO A, MUSKHELI V, PABON L, REINECKE H, MURRY CE (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21: 1345-1357.
70. OH H, BRADFUTE SB, GALLARDO TD, NAKAMURA T, GAUSSIN V, MISHINA Y, POCIUS J, MICHAEL LH, BEHRINGER RR, GARRY DJ, ENTMAN ML, SCHNEIDER MD (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100: 12313-12318.
71. OKITA K, NAKAGAWA M, HYENJONG H, ICHISAKA T, YAMANAKA S (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953.
72. ORLIC D, KAJSTURA J, CHIMENTI S, JAKONIUK I, ANDERSON SM, LI B, PICKEL J, MCKAY R, NADAL-GINARD B, BODINE DM, LERI A, ANVERSA P (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705.
73. PASSIER R, VAN LAAKE LW, MUMMERY CL (2008). Stem-cell-based therapy and lessons from the heart. Nature 453: 322-329.
74. PERIN EC, LOPEZ J (2006). Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med 3 Suppl 1: S110-113.
75. PITTENGER MF, MARTIN BJ (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20.
76. PLANAT-BENARD V, MENARD C, ANDRE M, PUCEAT M, PEREZ A, ARCIAVERDUGO JM, PENICAUD L, CASTEILLA L (2004). Spontaneouscardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94: 223-229.
77. PLANAT-BENARD V, SILVESTRE JS, COUSIN B, ANDRE M, NIBBELINK M, TAMARAT R, CLERGUE M, MANNEVILLE C, SAILLAN-BARREAU C, DURIEZ M, TEDGUI A, LEVY B, PENICAUD L, CASTEILLA L (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109: 656-663.
78. PONS J, HUANG Y, ARAKAWA-HOYT J, WASHKO D, TAKAGAWA J, YE J, GROSSMAN W, SU H (2008). VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochem Biophys Res Commun 376: 419-422.
79. PONS J, HUANG Y, TAKAGAWA J, ARAKAWA-HOYT J, YE J, GROSSMAN W, KAN YW, SU H (2009). Combining angiogenic gene and stem cell therapies for myocardial infarction. J Gene Med 11: 743-753.
80. PRICE MJ, CHOU CC, FRANTZEN M, MIYAMOTO T, KAR S, LEE S, SHAH PK, MARTIN BJ, LILL M, FORRESTER JS, CHEN PS, MAKKAR RR (2006). Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol 111: 231-239.
81. REFFELMANN T, KONEMANN S, KLONER RA (2009). Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol 53: 305-308.
82. SCHACHINGER V, AICHER A, DOBERT N, ROVER R, DIENER J, FICHTLSCHERER S, ASSMUS B, SEEGER FH, MENZEL C, BRENNER W, DIMMELER S, ZEIHER AM (2008). Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 118: 1425-1432.
83. SCHACHINGER V, ERBS S, ELSASSER A, HABERBOSCH W, HAMBRECHT R, HOLSCHERMANN H, YU J, CORTI R, MATHEY DG, HAMM CW, SUSELBECK T, ASSMUS B, TONN T, DIMMELER S, ZEIHER AM (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221.
84. SCHACHINGER V, ERBS S, ELSASSER A, HABERBOSCH W, HAMBRECHT R, HOLSCHERMANN H, YU J, CORTI R, MATHEY DG, HAMM CW, SUSELBECK T, WERNER N, HAASE J, NEUZNER J, GERMING A, MARK B, ASSMUS B, TONN T, DIMMELER S, ZEIHER AM (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27: 2775-2783.
85. SCHULERI KH, AMADO LC, BOYLE AJ, CENTOLA M, SALIARIS AP, GUTMAN MR, HATZISTERGOS KE, OSKOUEI BN, ZIMMET JM, YOUNG RG, HELDMAN AW, LARDO AC, HARE JM (2008). Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 294: H2002-2011.
86. SEGERS VF, LEE RT (2008). Stem-cell therapy for cardiac disease. Nature 451: 937-942.
87. SHAO H, TAN Y, ETON D, YANG Z, UBERTI MG, LI S, SCHULICK A, YU H (2008). Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells 26: 1376-1384.
88. SHERMAN W, MARTENS TP, VILES-GONZALEZ JF, SIMINIAK T (2006). Catheter- based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med.3 Suppl 1: S57-S64.
89. SIEVEKING DP, BUCKLE A, CELERMAJER DS, NG MK (2008). Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 51: 660-668.
90. SMITH AG (2001). Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 17: 435-462.
91. SMITH RR, BARILE L, MESSINA E, MARBAN E (2008). Stem cells in the heart: what's the buzz all about?-Part 1: preclinical considerations. Heart Rhythm 5: 749-757.
92. SMITS PC, VAN GEUNS RJ, POLDERMANS D, BOUNTIOUKOS M, ONDERWATER EE, LEE CH, MAAT AP, SERRUYS PW (2003). Catheterbased intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42: 2063-2069.
93. SORRENTINO SA, BAHLMANN FH, BESLER C, MULLER M, SCHULZ S, KIRCHHOFF N, DOERRIES C, HORVATH T, LIMBOURG A, LIMBOURG F, FLISER D, HALLER H, DREXLER H, LANDMESSER U (2007). Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferatoractivated receptor-gamma agonist rosiglitazone. Circulation.116:163-173.
94. SPYRIDOPOULOS I, HAENDELER J, URBICH C, BRUMMENDORF TH, OH H, SCHNEIDER MD, ZEIHER AM, DIMMELER S (2004). Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation.110:3136-3142.
95. STRAUER BE, BREHM M, ZEUS T, KOSTERING M, HERNANDEZ A, SORG RV, KOGLER G, WERNET P (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106:1913-1918.
96. SUAREZ Y, FERNANDEZ-HERNANDO C, POBER JS, SESSA WC (2007). Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res.100:1164-1173.
97. SUAREZ Y, SESSA WC (2009). MicroRNAs as novel regulators of angiogenesis. Circ Res 104: 442-454.
98. TAKAHASHI K, TANABE K, OHNUKI M, NARITA M, ICHISAKA T, TOMODA K, YAMANAKA S (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
99. TANG J, WANG J, YANG J, KONG X, ZHENG F, GUO L, ZHANG L, HUANG Y (2009). Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 36: 644-650.
100. TANG YL, TANG Y, ZHANG YC, QIAN K, SHEN L, PHILLIPS MI (2005). Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46: 1339-1350.
101. TEMPLIN C, KOTLARZ D, MARQUART F, FAULHABER J, BRENDECKE V, SCHAEFER A, TSIKAS D, BONDA T, HILFIKER-KLEINER D, OHL L, NAIM HY, FOERSTER R, DREXLER H, LIMBOURG FP (2006). Transcoronary delivery of bone marrow cells to the infarcted murine myocardium: feasibility, cellular kinetics, and improvement in cardiac function. Basic Res Cardiol 101: 301-310.
102. TEMPLIN C, KOTLARZ D, RATHINAM C, RUDOLPH C, SCHATZLEIN S, RAMIREDDY K, RUDOLPH KL, SCHLEGELBERGER B, KLEIN C, DREXLER H (2008). Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Exp Hematol 36: 204-215.
103. TEMPLIN C, KOTLARZ D, FAULHABER J, SCHNABEL S, GROTE K, SALGUERO G, LUCHTEFELD M, HILLER KH, JAKOB P, NAIM HY, SCHIEFFER B, HILFIKER-KLEINER D, LANDMESSER U, LIMBOURG FP, DREXLER H (2008). Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose. J Mol Cell Cardiol 45: 394-403.
104. TEMPLIN C, LUESCHER TF, LANDMESSER U (2010). Stem and progenitor cellbased therapy approaches: current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy. [Article in German]. Herz. 35: 445-456.
105. TENDERA M, WOJAKOWSKI W, RUZYLLO W, CHOJNOWSKA L, KEPKA C, TRACZ W, MUSIALEK P, PIWOWARSKA W, NESSLER J, BUSZMAN P, GRAJEK S, BREBOROWICZ P, MAJKA M, RATAJCZAK MZ (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 30: 1313-1321.
106. THOMPSON CA, NASSERI BA, MAKOWER J, HOUSER S, MCGARRY M, LAMSON T, POMERANTSEVA I, CHANG JY, GOLD HK, VACANTI JP, OESTERLE SN (2003). Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 41: 1964-1971.
107. TOMA C, PITTENGER MF, CAHILL KS, BYRNE BJ, KESSLER PD (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
108. TOMITA S, LI RK, WEISEL RD, MICKLE DA, KIM EJ, SAKAI T, JIA ZQ (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: II247-256.
109. TOSSIOS P, KRAUSGRILL B, SCHMIDT M, FISCHER T, HALBACH M, FRIES JW, FAHNENSTICH S, FROMMOLT P, HEPPELMANN I, SCHMIDT A, SCHOMACKER K, FISCHER JH, BLOCH W, MEHLHORN U, SCHWINGER RH, MULLER-EHMSEN J (2008). Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. Eur Heart J 29: 1911-1921.
110. UEMURA R, XU M, AHMAD N, ASHRAF M (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421.
111. URBICH C, AICHER A, HEESCHEN C, DERNBACH E, HOFMANN WK, ZEIHER AM, DIMMELER S (2005). Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39: 733-742.
112. URBICH C, DIMMELER S (2004). Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353.
113. VAN LAAKE LW, PASSIER R, DOEVENDANS PA, MUMMERY CL (2008). Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 102: 1008-1010.
114. VAN ROOIJ E, MARSHALL WS, OLSON EN (2008). Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 103: 919-928.
115. VASA M, FICHTLSCHERER S, AICHER A, ADLER K, URBICH C, MARTIN H, ZEIHER AM, DIMMELER S (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-7.
116. VULLIET PR, GREELEY M, HALLORAN SM, MACDONALD KA, KITTLESON MD (2004). Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363: 783-784.
117. WOLLERT KC, MEYER GP, LOTZ J, RINGES-LICHTENBERG S, LIPPOLT P, BREIDENBACH C, FICHTNER S, KORTE T, HORNIG B, MESSINGER D, ARSENIEV L, HERTENSTEIN B, GANSER A, DREXLER H (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148.
118. YANG J, ZHOU W, ZHENG W, MA Y, LIN L, TANG T, LIU J, YU J, ZHOU X, HU J (2007). Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107: 17-29.
119. YU J, VODYANIK MA, SMUGA-OTTO K, ANTOSIEWICZ-BOURGET J, FRANE JL, TIAN S, NIE J, JONSDOTTIR GA, RUOTTI V, STEWART R, SLUKVIN, II, THOMSON JA (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
120. ZARUBA MM, THEISS HD, VALLASTER M, MEHL U, BRUNNER S, DAVID R, FISCHER R, KRIEG L, HIRSCH E, HUBER B, NATHAN P, ISRAEL L, IMHOF A, HERBACH N, ASSMANN G, WANKE R, MUELLER-HOECKER J, STEINBECK G, FRANZ WM (2009). Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 4: 313-323.
121. ZHANG J, WILSON GF, SOERENS AG, KOONCE CH, YU J, PALECEK SP, THOMSON JA, KAMP TJ (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30-41.
122. ZHAO T, ZHANG D, MILLARD RW, ASHRAF M, WANG Y (2009). Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling. Am J Physiol Heart Circ Physiol 296: H976-H986.